{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T18:51:02.582773+00:00","published_at":"2026-10-17T04:47:07.293807+00:00","section":"relationships","data":{"state":"PUBLISHED","relationships":[{"relationship_id":"alpha:relationship:seat_on:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:5:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","relationship_type":"seat_on","from_id":"alpha:person:erik-manting-phd","to_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","from_label":"Erik Manting, PhD","to_label":"Transcode Therapeutics, Inc.","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:99edae6b52d719d70afd287661defb6df06b5f0c660bac24f748dfd49c63a311"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:6:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","relationship_type":"seat_on","from_id":"alpha:person:magda-marquet-ph-d","to_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","from_label":"Magda Marquet, PhD","to_label":"Transcode Therapeutics, Inc.","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:99edae6b52d719d70afd287661defb6df06b5f0c660bac24f748dfd49c63a311"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:7:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","relationship_type":"seat_on","from_id":"alpha:person:philippe-p-calais-pharmd-phd","to_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","from_label":"Philippe P. Calais, PharmD, PhD","to_label":"Transcode Therapeutics, Inc.","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:99edae6b52d719d70afd287661defb6df06b5f0c660bac24f748dfd49c63a311"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:8:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","relationship_type":"seat_on","from_id":"alpha:person:thomas-a-fitzgerald","to_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","from_label":"Thomas A. Fitzgerald","to_label":"Transcode Therapeutics, Inc.","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:99edae6b52d719d70afd287661defb6df06b5f0c660bac24f748dfd49c63a311"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:10:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","relationship_type":"committee_of","from_id":"alpha:committee:transcode-therapeutics-inc:audit","to_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","from_label":"Audit","to_label":"Transcode Therapeutics, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:10","evidence_ids":["alpha:projection-evidence:86ca7909a03c579f66d300c668b8d3067cf26daf06e91abeace1b14b1559271a"]},{"relationship_id":"alpha:relationship:chairs:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:10:committee:transcode-therapeutics-inc:audit","relationship_type":"chairs","from_id":"alpha:person:philippe-p-calais-pharmd-phd","to_id":"alpha:committee:transcode-therapeutics-inc:audit","from_label":"Philippe P. Calais, PharmD, PhD","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:10","evidence_ids":["alpha:projection-evidence:86ca7909a03c579f66d300c668b8d3067cf26daf06e91abeace1b14b1559271a"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:10:committee:transcode-therapeutics-inc:audit","relationship_type":"member_of","from_id":"alpha:person:erik-manting-phd","to_id":"alpha:committee:transcode-therapeutics-inc:audit","from_label":"Erik Manting, PhD","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:10","evidence_ids":["alpha:projection-evidence:86ca7909a03c579f66d300c668b8d3067cf26daf06e91abeace1b14b1559271a"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:7:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","relationship_type":"committee_of","from_id":"alpha:committee:transcode-therapeutics-inc:audit-chair-compensation-nominating-and-governance","to_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","from_label":"Audit · Chair; Compensation; Nominating and Governance","to_label":"Transcode Therapeutics, Inc.","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:99edae6b52d719d70afd287661defb6df06b5f0c660bac24f748dfd49c63a311"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:7:committee:transcode-therapeutics-inc:audit-chair-compensation-nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:philippe-p-calais-pharmd-phd","to_id":"alpha:committee:transcode-therapeutics-inc:audit-chair-compensation-nominating-and-governance","from_label":"Philippe P. Calais, PharmD, PhD","to_label":"Audit · Chair; Compensation; Nominating and Governance","valid_from":"2018-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:99edae6b52d719d70afd287661defb6df06b5f0c660bac24f748dfd49c63a311"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:5:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","relationship_type":"committee_of","from_id":"alpha:committee:transcode-therapeutics-inc:audit-compensation-nominating-and-governance-chair","to_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","from_label":"Audit; Compensation; Nominating and Governance · Chair","to_label":"Transcode Therapeutics, Inc.","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:99edae6b52d719d70afd287661defb6df06b5f0c660bac24f748dfd49c63a311"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:5:committee:transcode-therapeutics-inc:audit-compensation-nominating-and-governance-chair","relationship_type":"member_of","from_id":"alpha:person:erik-manting-phd","to_id":"alpha:committee:transcode-therapeutics-inc:audit-compensation-nominating-and-governance-chair","from_label":"Erik Manting, PhD","to_label":"Audit; Compensation; Nominating and Governance · Chair","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:99edae6b52d719d70afd287661defb6df06b5f0c660bac24f748dfd49c63a311"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:13:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","relationship_type":"committee_of","from_id":"alpha:committee:transcode-therapeutics-inc:compensation","to_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","from_label":"Compensation","to_label":"Transcode Therapeutics, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:13","evidence_ids":["alpha:projection-evidence:86ca7909a03c579f66d300c668b8d3067cf26daf06e91abeace1b14b1559271a"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:13:committee:transcode-therapeutics-inc:compensation","relationship_type":"member_of","from_id":"alpha:person:erik-manting-phd","to_id":"alpha:committee:transcode-therapeutics-inc:compensation","from_label":"Erik Manting, PhD","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:13","evidence_ids":["alpha:projection-evidence:86ca7909a03c579f66d300c668b8d3067cf26daf06e91abeace1b14b1559271a"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:16:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","relationship_type":"committee_of","from_id":"alpha:committee:transcode-therapeutics-inc:nominating-and-governance","to_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","from_label":"Nominating and Governance","to_label":"Transcode Therapeutics, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:16","evidence_ids":["alpha:projection-evidence:86ca7909a03c579f66d300c668b8d3067cf26daf06e91abeace1b14b1559271a"]},{"relationship_id":"alpha:relationship:chairs:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:16:committee:transcode-therapeutics-inc:nominating-and-governance","relationship_type":"chairs","from_id":"alpha:person:erik-manting-phd","to_id":"alpha:committee:transcode-therapeutics-inc:nominating-and-governance","from_label":"Erik Manting, PhD","to_label":"Nominating and Governance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:16","evidence_ids":["alpha:projection-evidence:86ca7909a03c579f66d300c668b8d3067cf26daf06e91abeace1b14b1559271a"]},{"relationship_id":"alpha:relationship:member_of:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:16:committee:transcode-therapeutics-inc:nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:philippe-p-calais-pharmd-phd","to_id":"alpha:committee:transcode-therapeutics-inc:nominating-and-governance","from_label":"Philippe P. Calais, PharmD, PhD","to_label":"Nominating and Governance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:16","evidence_ids":["alpha:projection-evidence:86ca7909a03c579f66d300c668b8d3067cf26daf06e91abeace1b14b1559271a"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:9:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","relationship_type":"executive_of","from_id":"alpha:person:zdravka-medarova","to_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","from_label":"Zdravka Medarova","to_label":"Transcode Therapeutics, Inc.","valid_from":"2026-04-15","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:43c8e9b7ecc3d53ce2fbda0adb3d46f711ec7c366cb81a9abb0e12eaf1fcda59"]}]},"claims":[{"id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:5","subject_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:erik-manting-phd","object_label":"Erik Manting, PhD","object_source_name_forms":[],"value":"Erik Manting, PhD: Director, Audit; Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:erik-manting-phd","name":"Erik Manting, PhD"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:document:99edae6b52d719d70afd287661defb6df06b5f0c660bac24f748dfd49c63a311","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Transcode Therapeutics, Inc. DEF 14A 2025-07-15","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465925068095/tm2520574-1_def14a.htm","source_date":"2025-07-15","retrieved_at":"2026-04-28T23:02:02.069+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-07-15","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:6","subject_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:magda-marquet-ph-d","object_label":"Magda Marquet, PhD","object_source_name_forms":[],"value":"Magda Marquet, PhD: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:magda-marquet-ph-d","name":"Magda Marquet, PhD"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:document:99edae6b52d719d70afd287661defb6df06b5f0c660bac24f748dfd49c63a311","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Transcode Therapeutics, Inc. DEF 14A 2025-07-15","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465925068095/tm2520574-1_def14a.htm","source_date":"2025-07-15","retrieved_at":"2026-04-28T23:02:02.069+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-07-15","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:7","subject_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:philippe-p-calais-pharmd-phd","object_label":"Philippe P. Calais, PharmD, PhD","object_source_name_forms":[],"value":"Philippe P. Calais, PharmD, PhD: Director, Audit · Chair; Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:philippe-p-calais-pharmd-phd","name":"Philippe P. Calais, PharmD, PhD"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:document:99edae6b52d719d70afd287661defb6df06b5f0c660bac24f748dfd49c63a311","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Transcode Therapeutics, Inc. DEF 14A 2025-07-15","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465925068095/tm2520574-1_def14a.htm","source_date":"2025-07-15","retrieved_at":"2026-04-28T23:02:02.069+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-07-15","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:8","subject_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:thomas-a-fitzgerald","object_label":"Thomas A. Fitzgerald","object_source_name_forms":[],"value":"Thomas A. Fitzgerald: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:thomas-a-fitzgerald","name":"Thomas A. Fitzgerald"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:document:99edae6b52d719d70afd287661defb6df06b5f0c660bac24f748dfd49c63a311","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Transcode Therapeutics, Inc. DEF 14A 2025-07-15","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465925068095/tm2520574-1_def14a.htm","source_date":"2025-07-15","retrieved_at":"2026-04-28T23:02:02.069+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-07-15","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:leadership_role:9","subject_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:zdravka-medarova","object_label":"Zdravka Medarova","object_source_name_forms":[],"value":"Zdravka Medarova: Chief Scientific Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:zdravka-medarova","name":"Zdravka Medarova"},"title":"Chief Scientific Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-15","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-15","valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:document:43c8e9b7ecc3d53ce2fbda0adb3d46f711ec7c366cb81a9abb0e12eaf1fcda59","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RNAZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465926043810/rnaz-20251231x10k.htm","source_date":"2026-04-15T00:00:00+00:00","retrieved_at":"2026-05-16T07:43:19.674807+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-15T00:00:00+00:00","effective_from":"2026-04-15","effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:10","subject_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Philippe P. Calais, PharmD, PhD; Members Philippe P. Calais, PharmD, PhD (Chair); Erik Manting, PhD","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Philippe P. Calais, PharmD, PhD","members":[{"display_name":"Philippe P. Calais, PharmD, PhD","person_slug":"philippe-p-calais-pharmd-phd","is_chair":true},{"display_name":"Erik Manting, PhD","person_slug":"erik-manting-phd","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:86ca7909a03c579f66d300c668b8d3067cf26daf06e91abeace1b14b1559271a","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465925068095/tm2520574-1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:13","subject_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair not stated; Members Erik Manting, PhD; Philippe P. Calais, PharmD, PhD","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":null,"members":[{"display_name":"Erik Manting, PhD","person_slug":"erik-manting-phd","is_chair":false},{"display_name":"Philippe P. Calais, PharmD, PhD","person_slug":"philippe-p-calais-pharmd-phd","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:86ca7909a03c579f66d300c668b8d3067cf26daf06e91abeace1b14b1559271a","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465925068095/tm2520574-1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37:committee_record:16","subject_id":"alpha:company:1750c6d2-2f92-47bb-b3f3-373c08b90e37","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Erik Manting, PhD; Members Erik Manting, PhD (Chair); Philippe P. Calais, PharmD, PhD","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Erik Manting, PhD","members":[{"display_name":"Erik Manting, PhD","person_slug":"erik-manting-phd","is_chair":true},{"display_name":"Philippe P. Calais, PharmD, PhD","person_slug":"philippe-p-calais-pharmd-phd","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:47:07.293807+00:00","sources":[{"id":"alpha:projection-evidence:86ca7909a03c579f66d300c668b8d3067cf26daf06e91abeace1b14b1559271a","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465925068095/tm2520574-1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:99edae6b52d719d70afd287661defb6df06b5f0c660bac24f748dfd49c63a311","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Transcode Therapeutics, Inc. DEF 14A 2025-07-15","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465925068095/tm2520574-1_def14a.htm","source_date":"2025-07-15","retrieved_at":"2026-04-28T23:02:02.069+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:43c8e9b7ecc3d53ce2fbda0adb3d46f711ec7c366cb81a9abb0e12eaf1fcda59","identity_scope":"source_document_reference","source_type":"sec_filing","title":"RNAZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465926043810/rnaz-20251231x10k.htm","source_date":"2026-04-15T00:00:00+00:00","retrieved_at":"2026-05-16T07:43:19.674807+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:86ca7909a03c579f66d300c668b8d3067cf26daf06e91abeace1b14b1559271a","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465925068095/tm2520574-1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.826,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.856,"cross_source_agreement":0.75,"temporal_completeness":0.455},"diagnostics":{"published_claims":18,"factual_claims":18,"claims_with_linked_evidence":18,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":11,"temporal_claims_with_valid_from":5,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:47:07.293807+00:00","observed_at":"2026-10-17T04:47:07.293807+00:00","reviewed_at":"2026-10-17T04:47:07.293807+00:00","verified_at":"2026-10-17T04:47:07.293807+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":18,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/transcode-therapeutics-inc/relationships","section":"relationships","href":"https://registry.alpha.ac/api/public/companies/transcode-therapeutics-inc?format=record&section=relationships","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}